262,851 Shares in Intuitive Surgical, Inc. $ISRG Purchased by SurgoCap Partners LP

SurgoCap Partners LP purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 262,851 shares of the medical equipment provider’s stock, valued at approximately $148,868,000. Intuitive Surgical comprises approximately 4.1% of SurgoCap Partners LP’s holdings, making the stock its 10th largest holding.

Several other institutional investors also recently bought and sold shares of ISRG. Norges Bank purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $2,856,987,000. Northwestern Mutual Wealth Management Co. raised its position in Intuitive Surgical by 1,043.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after acquiring an additional 1,224,734 shares in the last quarter. Polen Capital Management LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $477,225,000. Assenagon Asset Management S.A. raised its position in Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after acquiring an additional 791,516 shares in the last quarter. Finally, Amundi raised its position in Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after acquiring an additional 739,444 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $416.55 on Tuesday. The stock has a market capitalization of $147.53 billion, a PE ratio of 50.49, a price-to-earnings-growth ratio of 3.28 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $396.68 and a 12 month high of $603.88. The business has a 50 day simple moving average of $442.17 and a 200-day simple moving average of $494.54.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business’s revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.81 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Insider Activity

In other news, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the sale, the director directly owned 120 shares in the company, valued at $55,620. The trade was a 49.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock worth $3,059,135 over the last three months. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ISRG. Evercore reduced their price target on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research report on Monday, April 6th. Leerink Partners reduced their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Bank of America reduced their price target on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating for the company in a research report on Monday, May 18th. UBS Group reduced their price target on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Finally, BTIG Research reiterated a “buy” rating and set a $574.00 price target on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $571.28.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.